CFRA analyst Stewart Glickman downgraded Helmerich & Payne (NYSE:HP) shares from Buy to Sell, significantly reducing the price target from $39.00 to $25.00. The revised target comes with a lowered ...
Some results have been hidden because they may be inaccessible to you